Results 41 to 50 of about 10,268 (212)

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives A ‘gray color sign’ (GCS) is a new endoscopic feature of fundic gland polyp associated with proton pump inhibitor (PPI‐FGP). Here, we compare the ability of texture and color enhancement imaging (TXI) to white light imaging (WLI) with regard to the detection of GCS. Methods In this prospective study, 19 consecutive patients with PPI‐
Ryota Uchida   +17 more
wiley   +1 more source

A New Synthetic Process of Lansoprazole.

open access: yesChemInform, 2002
AbstractFor Abstract see ChemInform Abstract in Full Text.
Hyun Tae Shin   +6 more
openaire   +4 more sources

Lansoprazole-induced osteoporosis via the IP3R- and SOCE-mediated calcium signaling pathways

open access: yesMolecular Medicine, 2022
Background Many clinical studies have shown a correlation between proton pump inhibitors (PPIs) and osteoporosis or fractures. The purpose of this study was to establish a murine model of chronic oral PPI administration to verify whether PPIs caused bone
Ziping Cheng   +11 more
doaj   +1 more source

Combined Curcumin and Lansoprazole-Loaded Bioactive Solid Self-Nanoemulsifying Drug Delivery Systems (Bio-SSNEDDS)

open access: yesPharmaceutics, 2021
Background: The current study aimed to design a novel combination of lansoprazole (LNS) and curcumin (CUR) solid oral dosage form using bioactive self-nanoemulsifying drug delivery systems (Bio-SSNEDDS).
Abdulrahman Alshadidi   +4 more
doaj   +1 more source

Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 337-342, August 2025.
Older adults (65 years and over) frequently manage complex medication regimens and are vulnerable to adverse drug reactions and treatment inefficacies, some of which could be preventable with pharmacogenetics (PGx)‐guided prescribing. This study examined the prevalence of actionable PGx genotypes (i.e., those linked to a guideline that recommends a ...
Chad A. Bousman   +14 more
wiley   +1 more source

Lansoprazole in treatment of duodenal ulcer desease

open access: yesМедицинский совет, 2019
The duodenum ulcer disease (DUD) has high specific weight among digestive tract pathologies, influencing working capacity and quality of life of patients.
V. V. Skvortsov   +2 more
doaj   +1 more source

Degradation of lansoprazole and omeprazole in the aquatic environment

open access: yesChemosphere, 2006
Lansoprazole and omeprazole degrade in water leading to sulfides, benzimidazolones and a red complex material. Degradation is accelerated in acid medium and by solar simulator irradiation. Benzimidazoles, dianilines and pyridines have also been identified.
DELLA GRECA, MARINA   +5 more
openaire   +4 more sources

Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability

open access: yesBrazilian Journal of Medical and Biological Research, 2007
The effect of proton pump inhibitors and Helicobacter pylori infection on the bioavailability of antibiotics is poorly understood. We determined the effects of 5-day oral administration of 60 mg lansoprazole on the bioavailability of clarithromycin in ...
R.A.M. Ortiz   +8 more
doaj  

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice

open access: yesInfection and Drug Resistance, 2021
Kuo-Tung Hung,1 Shih-Cheng Yang,1 Cheng-Kun Wu,1,2 Hsing-Ming Wang,1 Chih-Chien Yao,1 Chih-Ming Liang,1,2 Wei-Chen Tai,1,2 Keng-Liang Wu,1,2 Yuan-Hung Kuo,1,2 Chen-Hsiang Lee,2,3 Seng-Kee Chuah1,2 1Division of Hepatogastroenterology, Department of ...
Hung KT   +10 more
doaj  

Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study

open access: yesGut and Liver, 2016
Background/Aims To evaluate changes in gut microbiota composition following long-term proton pump inhibitor (PPI) treatment. Methods : Twenty-four-week-old F344 rats were fed diets with (n=6) or without (n=5) lansoprazole for 50 weeks.
Cheol Min Shin   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy